Cite
HARVARD Citation
Ramachandran, R. et al. (2022). Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patients. International journal of infectious diseases. pp. 62-69. [Online].